Built by Pharma
for Pharma

Lokavant was founded within a biopharma company to address the data challenges of planning and conducting complex, global clinical studies.

Our mission is to make clinical trials intelligent

Lokavant was born to improve clinical trial performance by providing study teams with a Clinical Trial Intelligence Platform. Our platform delivers real-time, AI-driven data insights that enable researchers to design, plan, and execute trials more efficiently while boosting their confidence in making well-informed decisions.

Our vision is to empower clinical researchers with AI-powered intelligence to improve trial performance and operations


As pharma focuses more on developing specialized therapies, studies are more difficult to plan and execute, given:

Patients must fit within a more complex eligibility criteria
Data sources are more varied across each study
Specialized trials require many specialized vendors - but there is no common, connected infrastructure

Lokavant's Clinical Trial Intelligence Platform ingests, aggregates, and standardizes data from any source in real-time to uncover actionable and predictive insights to improve trial performance, compliance, and mitigate risk.

Our Team

A multi-disciplinary team of clinical operators and technologists focused on transforming drug development to improve patient lives and enable life sciences companies to bring life changing therapies to patients.

Board of Directors

Gregg Michaelson

General Partner, Edison Partners

Alex Gasner

Executive Vice President, Roivant Health

Matt Giles

Vice President, Roivant Health

Jeff Kozloff

Former CEO Trialscope and Verilogue

Our Advisors

Craig Lipset

Founder, Clinical Innovation Partners

Marie Rosenfeld

Senior Vice President, Head of Clinical Sciences, Astellas Pharma

Mark Weinberg

Former President and CMO, Avillion

Greer Chambers

Director, Clinical Operations, Moderna

Angela Radcliffe

R&D Digital Performance Improvement & Innovation, Bristol Myers Squibb

Marcella Rogers

Former SVP & Head of Operations and Portfolio Management, Sumitovant Biopharma, Inc

Bill Symonds

CEO, Enzyvant

Milind Kamkolkar

COO, Paradigm

We’re hiring.

We are a passionate team of clinical experts, technologists, and product evangelists laser-focused on solving some of the biggest challenges in clinical development to ultimately bring new medicines to patients faster and more efficiently. 

We care deeply for each other and the partners and patients that our products are built to serve.  If that sounds like you, we’d love to meet you!